12 month reduction in trial timelines through 2026 real-time analysis
The primary benchmark of clinical success in 2026 has become the speed of data-to-decision. By utilizing "streaming analytics," pharmaceutical companies are no longer waiting for quarterly data locks to assess trial progress. Instead, automated dashboards provide daily insights into safety and efficacy, allowing for the early termination of failed programs and the acceleration of breakthrough...
0 Commentarii 0 Distribuiri 182 Views 0 previzualizare